GvHD予防に基づく高リスク骨髄性新生体の患者における再発後の低濃度コンディショニング: PTCy vs. TAC/ MTX
Khalil Hassan1, Anmol Baranwal1,2, Al Rabee Kassis1
1Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
American journal of hematology
|September 4, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
8.0K
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.3K
